VENTURE CAPITAL POST

The US Food and Drug Administration (FDA) has approved a new drug called Xolair that could be life-changing for those with severe food allergies.

President Barrack Obama seeks an additional $1.1 billion in the face of increasing death rates due to overdoses of heroin and opioids. The Obama administration has already split the amount and categorized them to focus on different aspects like increasing medical-assisted facilities, prescriptions of antidotes, plans for overdose prevention, etc. These facilities are to be rolled out to the rural areas as well.

The U.S. Food and Drug Administration has expanded the authorized use of Celgene Corp's cancer drug Revlimid to include newly diagnosed patients with multiple myeloma, the company said on Wednesday.

Vernalis plc and Tris Pharma, Inc. ("Tris") are pleased to announce that the U.S. Food and Drug Administration ("FDA") has confirmed that the New Drug Application ("NDA") for Tuzistra™ XR ("CCP-01") has been accepted for full review. This triggers a milestone payment from Vernalis to Tris.

Bristol-Myers Squibb Co on Thursday filed a lawsuit against Merck & Co Inc for allegedly infringing its immunotherapy patent. The company is seeking unspecified damages.

For a growing U.S. aging population, tracking heart health via a smartphone can mean the difference between life and death. This week, two Silicon Valley startups received a green-light from the U.S. Food and Drug Administration for mobile applications

Home genetics startup 23andMe has secured a $1.4 million two-year grant from the National Institutes of Health (NIH) to build survey tools and expand its gene database.

US-based specialty healthcare company Endo Health Solutions Inc agreed to purchase pharmaceutical firm NuPathe Inc in a deal valued at $105 million for its new migraine medication.